Suresh Ramasubban

TL;DR: These guidelines, written for clinicians, contains evidence-based recommendations for the prevention of hospital acquired infections Hospital acquired infections are a major cause of mortality and morbidity and provide challenge to clinicians.

TL;DR: NIV should be used in management of acute exacerbation of COPD in patients with acute or acute-on-chronic respiratory acidosis, and NIV may be used over conventional oxygen therapy in mild early acute hypoxemic respiratory failure, under close supervision.

TL;DR: Polymyxin B has acceptable effectiveness against nosocomial multidrug resistant Gram-negative sepsis and the associated nephrotoxicity has been found to be significantly lower than previously reported even in patients with background renal impairment and established risk factors of renal failure.

TL;DR: In this article, the authors developed and validated individualized mortality risk scores based on the anonymized clinical and laboratory data at admission and determine the probability of Deaths at 7 and 28 days.

TL;DR: It is postulated that CT findings can be used to ascertain the overall disease burden and predict the clinical outcome and the severe CT-IS score group has a high mortality in COVID-19 patients.